Faeth Therapeutics, Inc.FTH
Price (close)
$29.05
Market cap
$750.7M
P/E
—
Revenue (TTM)
—
Net income
-$195.5M
Dividend yield
—
1-year total return
231.2%
Net margin
—
Revenue growth
—
Debt / equity
—
What Faeth Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | -$20.1M | -$36.8M | -$48.6M | -$34.1M | -$30.2M | -$21.1M |
| Free cash flow | -$18.9M | -$32.3M | -$39.3M | -$32.2M | -$24.8M | -$20.5M |
More on FTH.
- Faeth Therapeutics, Inc. summary
- Faeth Therapeutics, Inc. financial statements
- Faeth Therapeutics, Inc. key metrics
- Faeth Therapeutics, Inc. health scores and style box
- Faeth Therapeutics, Inc. earnings
- Faeth Therapeutics, Inc. dividends
- Faeth Therapeutics, Inc. valuation
- Faeth Therapeutics, Inc. ownership and insiders
- Faeth Therapeutics, Inc. peers
Figures from Faeth Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.